Credit Suisse’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$603K Sell
41,519
-321
-0.8% -$4.44K ﹤0.01% 2549
2023
Q4
$564K Sell
41,840
-699
-2% -$8.21K ﹤0.01% 2674
2023
Q3
$547K Sell
42,539
-1,123
-3% -$20.2K ﹤0.01% 2632
2023
Q2
$789K Buy
43,662
+2,434
+6% +$45.5K ﹤0.01% 2543
2023
Q1
$691K Buy
41,228
+21,537
+109% +$421K ﹤0.01% 2545
2022
Q4
$404K Buy
19,691
+5,296
+37% +$93.4K ﹤0.01% 2905
2022
Q3
$275K Buy
14,395
+114
+0.8% +$2.56K ﹤0.01% 3118
2022
Q2
$336K Sell
14,281
-2,260
-14% -$64.7K ﹤0.01% 3098
2022
Q1
$540K Buy
16,541
+2,088
+14% +$67.1K ﹤0.01% 2930
2021
Q4
$450K Buy
14,453
+828
+6% +$27.7K ﹤0.01% 3891
2021
Q3
$520K Sell
13,625
-2,157
-14% -$85.9K ﹤0.01% 3774
2021
Q2
$634K Sell
15,782
-168
-1% -$7.1K ﹤0.01% 3686
2021
Q1
$691K Sell
15,950
-3,305
-17% -$146K ﹤0.01% 3555
2020
Q4
$828K Buy
19,255
+5,610
+41% +$205K ﹤0.01% 3464
2020
Q3
$425K Buy
13,645
+1,942
+17% +$60.2K ﹤0.01% 3472
2020
Q2
$375K Sell
11,703
-2,683
-19% -$89K ﹤0.01% 3472
2020
Q1
$403K Sell
14,386
-3,178
-18% -$123K ﹤0.01% 3239
2019
Q4
$811K Buy
17,564
+1,711
+11% +$80.4K ﹤0.01% 3272
2019
Q3
$840K Buy
15,853
+4,219
+36% +$218K ﹤0.01% 3127
2019
Q2
$616K Sell
11,634
-6,132
-35% -$326K ﹤0.01% 3281
2019
Q1
$1M Buy
17,766
+411
+2% +$23.1K ﹤0.01% 2888
2018
Q4
$910K Buy
17,355
+5,293
+44% +$301K ﹤0.01% 2857
2018
Q3
$698K Sell
12,062
-7,739
-39% -$434K ﹤0.01% 3101
2018
Q2
$1.13M Sell
19,801
-4,210
-18% -$240K ﹤0.01% 2930
2018
Q1
$1.41M Buy
24,011
+8,900
+59% +$499K ﹤0.01% 2705
2017
Q4
$826K Sell
15,111
-8,642
-36% -$448K ﹤0.01% 3130
2017
Q3
$1.12M Buy
23,753
+14,476
+156% +$682K ﹤0.01% 3010
2017
Q2
$431K Sell
9,277
-7,342
-44% -$305K ﹤0.01% 3247
2017
Q1
$635K Sell
16,619
-30,557
-65% -$1.13M ﹤0.01% 3145
2016
Q4
$1.71M Buy
47,176
+25,749
+120% +$977K ﹤0.01% 2562
2016
Q3
$917K Sell
21,427
-12,020
-36% -$536K ﹤0.01% 3030
2016
Q2
$1.42M Sell
33,447
-20,715
-38% -$901K ﹤0.01% 2622
2016
Q1
$2.25M Buy
54,162
+27,500
+103% +$1.08M ﹤0.01% 2112
2015
Q4
$1.05M Buy
26,662
+11,570
+77% +$432K ﹤0.01% 2780
2015
Q3
$509K Sell
15,092
-16,606
-52% -$591K ﹤0.01% 3368
2015
Q2
$1.05M Buy
31,698
+18,126
+134% +$623K ﹤0.01% 3133
2015
Q1
$487K Sell
13,572
-11,987
-47% -$377K ﹤0.01% 3551
2014
Q4
$769K Buy
25,559
+2,090
+9% +$61.3K ﹤0.01% 3368
2014
Q3
$726K Sell
23,469
-3,362
-13% -$112K ﹤0.01% 3338
2014
Q2
$972K Sell
26,831
-25,771
-49% -$833K ﹤0.01% 3306
2014
Q1
$1.59M Sell
52,602
-78,325
-60% -$1.81M ﹤0.01% 2707
2013
Q4
$2.99M Buy
130,927
+29,944
+30% +$626K ﹤0.01% 2304
2013
Q3
$2.1M Buy
100,983
+12,174
+14% +$296K ﹤0.01% 2355
2013
Q2
$2.39M Buy
+88,809
New +$2.66M ﹤0.01% 2136

Other funds holding OFIX

Credit Suisse's OFIX Position: Q1 2024 in Review

Credit Suisse reduced its Orthofix Medical (OFIX) stake by 0.77% in Q1 2024, selling an estimated $4.44K and leaving 41,519 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Credit Suisse first reported a position in OFIX in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.99M in Q4 2013. 136 funds tracked by Wall St. Rank hold OFIX as of Q1 2024.

  • Credit Suisse held 41,519 shares of Orthofix Medical worth $603K as of Q1 2024.
  • Credit Suisse sold 321 Orthofix Medical shares in Q1 2024, an estimated $4.44K.
  • Orthofix Medical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2549 holding.
  • Credit Suisse first reported a position in Orthofix Medical in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Orthofix Medical position peaked at $2.99M in Q4 2013.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.